Molnupiravir, Bamlanivimab, Remdesivir, and Ivermectin Studies

Course Content
Pharmacology and Interventions
0/58
Pharmacology and Interventions
About Lesson

Molnupiravir, Bamlanivimab, Remdesivir, and Ivermectin Studies If authorized/approved, Merck’s Molnupiravir is an excellent new addition to the toolset for the physicians to manage COVID-19. I believe this will be the last straw for the SARS-COV-2 to become an endemic from a pandemic. Let’s review the timeline, trial, order placement, and possibly imminent EUA as compared to other drugs like Bamlanivimab, etc.